CHINA ISOTOPE & RADIATION CORPORATION Financials China Isotope & Radiation Corporation
Equities
1763
CNE1000031F4
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.92 HKD | -0.36% |
|
+0.92% | -18.26% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 4,354 | 6,017 | 7,242 | 5,734 | 3,780 | 3,884 |
| Enterprise Value (EV) 1 | 1,877 | 4,115 | 5,398 | 3,802 | 1,716 | 2,645 |
| P/E ratio | 11.8 x | 18.3 x | 33.9 x | 17.1 x | 9.65 x | 10.5 x |
| Yield | 2% | 0.74% | 0.8% | 2.11% | 3.73% | 2.58% |
| Capitalization / Revenue | 1.34 x | 1.51 x | 1.69 x | 1.11 x | 0.62 x | 0.59 x |
| EV / Revenue | 0.58 x | 1.03 x | 1.26 x | 0.74 x | 0.28 x | 0.4 x |
| EV / EBITDA | 2.8 x | 5.34 x | 7.48 x | 4.22 x | 1.63 x | 2.72 x |
| EV / FCF | -6.28 x | -26.5 x | -20 x | 22.4 x | 10.9 x | -3.29 x |
| FCF Yield | -15.9% | -3.77% | -4.99% | 4.47% | 9.14% | -30.4% |
| Price to Book | 1.25 x | 1.6 x | 1.86 x | 1.37 x | 0.85 x | 0.83 x |
| Nbr of stocks (in thousands) | 319,875 | 319,875 | 319,875 | 319,875 | 319,875 | 319,875 |
| Reference price 2 | 13.61 | 18.81 | 22.64 | 17.93 | 11.82 | 12.14 |
| Announcement Date | 4/26/19 | 4/28/20 | 4/20/21 | 4/27/22 | 4/26/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 3,238 | 3,989 | 4,274 | 5,144 | 6,146 | 6,635 |
| EBITDA 1 | 670.3 | 770.3 | 721.6 | 901.4 | 1,054 | 972.9 |
| EBIT 1 | 601.7 | 670 | 584.7 | 742.8 | 873.7 | 749.7 |
| Operating Margin | 18.58% | 16.8% | 13.68% | 14.44% | 14.21% | 11.3% |
| Earnings before Tax (EBT) 1 | 693.1 | 733.8 | 596.2 | 802.7 | 920.5 | 922.4 |
| Net income 1 | 323 | 329 | 213.6 | 335.8 | 391.6 | 371 |
| Net margin | 9.97% | 8.25% | 5% | 6.53% | 6.37% | 5.59% |
| EPS 2 | 1.157 | 1.029 | 0.6677 | 1.050 | 1.224 | 1.160 |
| Free Cash Flow 1 | -299 | -155.1 | -269.3 | 169.8 | 156.9 | -805 |
| FCF margin | -9.23% | -3.89% | -6.3% | 3.3% | 2.55% | -12.13% |
| FCF Conversion (EBITDA) | - | - | - | 18.84% | 14.88% | - |
| FCF Conversion (Net income) | - | - | - | 50.58% | 40.06% | - |
| Dividend per Share 2 | 0.2726 | 0.1389 | 0.1803 | 0.3779 | 0.4407 | 0.3131 |
| Announcement Date | 4/26/19 | 4/28/20 | 4/20/21 | 4/27/22 | 4/26/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 2,476 | 1,903 | 1,844 | 1,932 | 2,064 | 1,239 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -299 | -155 | -269 | 170 | 157 | -805 |
| ROE (net income / shareholders' equity) | 17.4% | 13.4% | 9.05% | 11.7% | 12% | 11.3% |
| ROA (Net income/ Total Assets) | 6.51% | 5.32% | 4.05% | 4.72% | 4.93% | 3.75% |
| Assets 1 | 4,964 | 6,187 | 5,269 | 7,109 | 7,946 | 9,890 |
| Book Value Per Share 2 | 10.80 | 11.80 | 12.20 | 13.10 | 14.00 | 14.70 |
| Cash Flow per Share 2 | 8.130 | 8.580 | 7.990 | 8.590 | 9.140 | 9.040 |
| Capex 1 | 751 | 591 | 410 | 428 | 534 | 898 |
| Capex / Sales | 23.19% | 14.81% | 9.59% | 8.32% | 8.69% | 13.53% |
| Announcement Date | 4/26/19 | 4/28/20 | 4/20/21 | 4/27/22 | 4/26/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.26% | 449M | |
| -1.19% | 12.56B | |
| -6.06% | 7.68B | |
| -0.28% | 5.29B | |
| +21.79% | 5.24B | |
| +2.05% | 4.57B | |
| -51.30% | 3.29B | |
| +7.80% | 2.6B | |
| -8.63% | 2.2B | |
| -0.96% | 1.79B |
- Stock Market
- Equities
- 1763 Stock
- Financials China Isotope & Radiation Corporation